Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs ZyVersa Therapeutics, Inc. (ZVSA)

Biodexa Pharmaceuticals PLC Unsponsored ADR and ZyVersa Therapeutics, Inc. are both Biotechnology companies. ZyVersa Therapeutics, Inc. is the larger, with a market value of $970.0K against $700.0K — 1.4× the size. ZyVersa Therapeutics, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 5 and ZyVersa Therapeutics, Inc. on 3.

Valuation

Metric BDRX ZVSA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales (2.81) n/m 10.73
Earnings yield (375.47%) (3,679.60%) (28.84%)
Free cash flow yield 0.00% (511.54%) (23.03%)

Profitability

Metric BDRX ZVSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 817.13% (57.72%)
Return on assets 0.00% (225.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDRX ZVSA Biotechnology median
Revenue growth (TTM) 60.22% — 5.64%
EPS growth (last fiscal year) 89.68% 50.71% —
Revenue growth, 5-year CAGR (28.78%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.41 0.05 4.73
Net debt to EBITDA 1.00 0.00 0.96

Dividend

Metric BDRX ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BDRX ZVSA Biotechnology median
Market cap 700.00k 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack